201 related articles for article (PubMed ID: 35689852)
21. LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis.
Xie T; Du K; Liu W; Liu C; Wang B; Tian Y; Li R; Huang X; Lin J; Jian H; Zhang J; Yuan Y
Br J Cancer; 2022 Oct; 127(7):1239-1253. PubMed ID: 35864158
[TBL] [Abstract][Full Text] [Related]
22. MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma.
Fan DC; Zhao YR; Qi H; Hou JX; Zhang TH
Auris Nasus Larynx; 2020 Aug; 47(4):632-642. PubMed ID: 31932074
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
24. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract][Full Text] [Related]
25. The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling.
Qiu WZ; Zhang HB; Xia WX; Ke LR; Yang J; Yu YH; Liang H; Huang XJ; Liu GY; Li WZ; Xiang YQ; Kang TB; Guo X; Lv X
J Exp Clin Cancer Res; 2018 Apr; 37(1):85. PubMed ID: 29665837
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
Chen M; Chen C; Luo H; Ren J; Dai Q; Hu W; Zhou K; Tang X; Li X
Cell Mol Biol Lett; 2020 Nov; 25(1):49. PubMed ID: 33292168
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.
Hwang CF; Shiu LY; Su LJ; Yu-Fang Yin ; Wang WS; Huang SC; Chiu TJ; Huang CC; Zhen YY; Tsai HT; Fang FM; Huang TL; Chen CH
PLoS One; 2013; 8(12):e84218. PubMed ID: 24386352
[TBL] [Abstract][Full Text] [Related]
28. LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis.
Hu W; Li H; Wang S
BMC Cancer; 2020 May; 20(1):376. PubMed ID: 32370736
[TBL] [Abstract][Full Text] [Related]
29. S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.
Meng DF; Sun R; Liu GY; Peng LX; Zheng LS; Xie P; Lin ST; Mei Y; Qiang YY; Li CZ; Xu L; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Guo LL; Xie DH; Shu DT; Li HF; Luo FF; Niu XT; Huang BJ; Qian CN
Oncogene; 2020 Jul; 39(30):5307-5322. PubMed ID: 32555330
[TBL] [Abstract][Full Text] [Related]
30. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
31. Foxq1 promotes metastasis of nasopharyngeal carcinoma by inducing vasculogenic mimicry via the EGFR signaling pathway.
Luo Y; Wang J; Wang F; Liu X; Lu J; Yu X; Ma X; Peng X; Li X
Cell Death Dis; 2021 Apr; 12(5):411. PubMed ID: 33875643
[TBL] [Abstract][Full Text] [Related]
32. Dysregulated NF-κB signal promotes the hub gene PCLAF expression to facilitate nasopharyngeal carcinoma proliferation and metastasis.
Ma F; Zhi C; Wang M; Li T; Khan SA; Ma Z; Jing Z; Bo C; Zhou Q; Xia S; Huang S; Huang S; Zhang Z; Jia H; Cui X; Yao M; Ji T
Biomed Pharmacother; 2020 May; 125():109905. PubMed ID: 32070873
[TBL] [Abstract][Full Text] [Related]
33. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
34. LINC00114 promoted nasopharyngeal carcinoma progression and radioresistance in vitro and in vivo through regulating ERK/JNK signaling pathway via targeting miR-203.
Han YY; Liu K; Xie J; Li F; Wang Y; Yan B
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2491-2504. PubMed ID: 32196600
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA cytoskeleton regulator RNA promotes cell invasion and metastasis by titrating miR-613 to regulate ANXA2 in nasopharyngeal carcinoma.
Chen W; Du M; Hu X; Ma H; Zhang E; Wang T; Yin L; He X; Hu Z
Cancer Med; 2020 Feb; 9(3):1209-1219. PubMed ID: 31859457
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miR-204 facilitates the progression of nasopharyngeal carcinoma by targeting CXCR4 through NF-κB signaling pathway.
Zong G; Han J; Yue Z; Liu Y; Cui Z; Shi L
J BUON; 2020; 25(2):1098-1104. PubMed ID: 32521912
[TBL] [Abstract][Full Text] [Related]
37. BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.
Wei F; Wu Y; Tang L; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
Br J Cancer; 2018 Jan; 118(2):233-247. PubMed ID: 29123267
[TBL] [Abstract][Full Text] [Related]
38. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
[TBL] [Abstract][Full Text] [Related]
39. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
[TBL] [Abstract][Full Text] [Related]
40. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
